The U.S. laparotomy sponge market size was valued at USD 422.7 million in 2024 and is projected to reach USD 706.9 million by 2033, growing at a CAGR of 5.9% from 2025 to 2033. Key factors driving growth include a rise in abdominal surgeries due to conditions such as cancer and hernias, as well as an increase in C-sections. Demand is further enhanced by concerns regarding retained surgical items, which have led to the adoption of radiopaque and RFID-enabled sponges. Additionally, the growth is fueled by the aging population, increased surgical volumes in outpatient settings, and advancements in sponge design and materials, all supported by regulatory emphasis on surgical safety and infection control.
Additionally, the U.S. is witnessing heightened focus on surgical safety, particularly in preventing retained surgical items (RSIs). RSIs, especially sponges, are among the most common and dangerous surgical errors, leading to severe complications, repeat surgeries, infections, and even fatalities. For instance, according to the National Quality Forum (NQF), 2,000-4,000 cases of retained surgical items (RSIs) are reported yearly in the U.S., where sponges are the most frequently retained objects.
Laparotomy sponges are used in sterile, high-bleeding-risk operations, including resections. According to the American Cancer Society, approximately 106,180 new colorectal cases were recorded in the U.S., many of which require open (laparotomy) procedures, where sponges are essential for fluid management and tissue retraction.
Sustainability, ergonomic design, and targeted customization are emerging as influential factors in the evolution of laparotomy sponges in the U.S. healthcare market. As hospitals increasingly prioritize environmentally responsible procurement, manufacturers are responding by developing laparotomy sponges made with eco-friendly materials, reduced packaging waste, and biodegradable components. These innovations align with broader institutional goals of lowering medical waste and achieving greener operating room practices. In a market that has historically focused on functionality and cost, sustainability is now becoming a competitive differentiator, especially among large hospital systems aiming to meet ESG (Environmental, Social, and Governance) targets.
In parallel, ergonomic design and procedure-specific customization are enhancing surgical efficiency and safety. Modern laparotomy sponges are being developed with features such as reinforced edges for easier retrieval, improved texture for better fluid absorption, and color-coded systems to assist in intraoperative tracking. Some products are even customized based on surgical specialty-such as gynecologic oncology or trauma care, ensuring optimal size, shape, and absorbency for the intended use.
This product will be delivered within 1-3 business days.
Additionally, the U.S. is witnessing heightened focus on surgical safety, particularly in preventing retained surgical items (RSIs). RSIs, especially sponges, are among the most common and dangerous surgical errors, leading to severe complications, repeat surgeries, infections, and even fatalities. For instance, according to the National Quality Forum (NQF), 2,000-4,000 cases of retained surgical items (RSIs) are reported yearly in the U.S., where sponges are the most frequently retained objects.
Laparotomy sponges are used in sterile, high-bleeding-risk operations, including resections. According to the American Cancer Society, approximately 106,180 new colorectal cases were recorded in the U.S., many of which require open (laparotomy) procedures, where sponges are essential for fluid management and tissue retraction.
Sustainability, ergonomic design, and targeted customization are emerging as influential factors in the evolution of laparotomy sponges in the U.S. healthcare market. As hospitals increasingly prioritize environmentally responsible procurement, manufacturers are responding by developing laparotomy sponges made with eco-friendly materials, reduced packaging waste, and biodegradable components. These innovations align with broader institutional goals of lowering medical waste and achieving greener operating room practices. In a market that has historically focused on functionality and cost, sustainability is now becoming a competitive differentiator, especially among large hospital systems aiming to meet ESG (Environmental, Social, and Governance) targets.
In parallel, ergonomic design and procedure-specific customization are enhancing surgical efficiency and safety. Modern laparotomy sponges are being developed with features such as reinforced edges for easier retrieval, improved texture for better fluid absorption, and color-coded systems to assist in intraoperative tracking. Some products are even customized based on surgical specialty-such as gynecologic oncology or trauma care, ensuring optimal size, shape, and absorbency for the intended use.
U.S. Laparotomy Sponge Market Report Segmentation
This report forecasts revenue growth at the country level and provides an analysis of the latest trends in each of the sub-segments from 2021 to 2033. The analyst has segmented the U.S. laparotomy sponge market report based on product and end-use:Product Outlook (Revenue, USD Million, 2021-2033)
- Radiopaque Laparotomy Sponge
- Traditional Laparotomy Sponge
- Radio-frequency Identification (RFID) Laparotomy Sponge
End-use Outlook (Revenue, USD Million, 2021-2033)
- Hospitals & Clinics
- Others
Why should you buy this report?
- Comprehensive Market Analysis: Gain detailed insights into the industry across major regions and segments.
- Competitive Landscape: Explore the market presence of key players.
- Future Trends: Discover the pivotal trends and drivers shaping the future of the market.
- Actionable Recommendations: Utilize insights to uncover new revenue streams and guide strategic business decisions.
This report addresses:
- Market intelligence to enable effective decision-making
- Market estimates and forecasts from 2018 to 2030
- Growth opportunities and trend analyses
- Segmental and regional revenue forecasts for market assessment
- Competition strategy and market share analysis
- Product innovation listings for you to stay ahead of the curve
- COVID-19's impact and how to sustain in these fast-evolving markets
This product will be delivered within 1-3 business days.
Table of Contents
Chapter 1. Methodology and Scope
Chapter 2. Executive Summary
Chapter 3. U.S. Laparotomy Sponge Market Variables, Trends & Scope
Chapter 4. U.S. Laparotomy Sponge Market: Product Estimates & Trend Analysis
Chapter 5. U.S. Laparotomy Sponge Market: End-use Estimates & Trend Analysis
Chapter 6. Competitive Landscape
List of Tables
List of Figures
Companies Mentioned
The major companies profiled in this U.S. Laparotomy Sponge market report include:- Integra LifeSciences
- Medical Action Industries Inc.
- SDP Inc.
- Dukal, LLC
- Stryker
- Cardinal Health
- AllCare
- DeRoyal Industries Inc.
- Allmed Medical Products Co., Ltd.
- Premier Enterprises
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 125 |
| Published | August 2025 |
| Forecast Period | 2024 - 2033 |
| Estimated Market Value ( USD | $ 422.7 Million |
| Forecasted Market Value ( USD | $ 706.9 Million |
| Compound Annual Growth Rate | 5.9% |
| Regions Covered | United States |
| No. of Companies Mentioned | 11 |
